KRAS inhibitor-33
KRAS inhibitor-33 (compound 115a) is a potent pyrido[2,3-d]pyrimidine-based KRAS inhibitor with an IC50 of ≤100 nM. This small molecule is a valuable research tool for investigating KRAS-driven cancers in both in vitro cellular assays and in vivo model studies.
Product Specifications
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Molecular Formula
C33H39ClF2N6O3
Molecular Weight
641.15
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-N825090-1MG 1 mg
(6Beta,17Alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-6,17-diol 6-(4-Nitrobenozoate)
Sign In for Pricing
View Details 
